Group 1: Apple Inc. - Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, remains long on Apple Inc. [1] - Wedbush analyst Dan Ives reiterated an Outperform rating for Apple and maintained a price target of $350 [1] - Apple shares gained 3.2% to close at $263.88 [5] Group 2: AstraZeneca PLC - AstraZeneca reported fourth-quarter 2025 sales of $15.50 billion, up 4% year over year, and adjusted earnings of $2.12 per share, beating the consensus of $2.09 [2] - Jim Lebenthal, partner at Cerity Partners, highlighted AstraZeneca as a high-quality pharmaceutical stock [1] - AstraZeneca shares rose 1.9% to close at $209.48 [5] Group 3: VICI Properties Inc. - VICI Properties has a 6% dividend yield according to Jenny Van Leeuwen Harrington, CEO of Gilman Hill Asset Management [2] - Scotiabank analyst Nicholas Yulico downgraded VICI Properties from Sector Outperform to Sector Perform and lowered the price target from $36 to $30 [3] - VICI Properties shares gained 1.9% to settle at $29.86 [5] Group 4: Ulta Beauty, Inc. - Ulta Beauty announced its first store opening in the United Arab Emirates, debuting at Mall of the Emirates on January 29 [4] - Joe Terranova, senior managing director for Virtus Investment Partners, named Ulta Beauty as his final trade [3] - Ulta Beauty shares gained 3.4% to close at $706.82 [5]
Apple, Ulta Beauty, AstraZeneca And A Real Estate Stock On CNBC's 'Final Trades' - Apple (NASDAQ:AAPL), AstraZeneca (NYSE:AZN)